Uwe Schlegel
St. Josef Hospital
Bochum, NW, Germany
Bochum, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
Journal: Journal of neuro-oncology
Published: November 03, 2023
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
Journal: Journal of neuro-oncology
Published: August 07, 2023
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up.
Journal: Journal of neuro-oncology
Published: July 10, 2023
Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis.
Journal: Neurological research and practice
Published: January 08, 2023
Outcome and prognostic factors of very old patients with primary CNS lymphoma: a retrospective analysis of patients ≥80 years treated with high-dose methotrexate-based chemotherapy.
Journal: Leukemia & lymphoma
Published: July 20, 2022
Pre- and postoperative self-reported and objectively assessed neurocognitive functioning in lower grade glioma patients.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: July 13, 2022
Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication.
Journal: Neurological research and practice
Published: June 17, 2022
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Journal: International journal of cancer
Published: May 19, 2022
Point-of-Care Testing Using a Neuropsychology Pocketcard Set: A Preliminary Validation Study.
Journal: Brain sciences
Published: May 02, 2022
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial.
Journal: BMC cancer
Published: April 19, 2022
Last Updated: 09/26/2026